Skip to main content

Table 4 Logistic regression analyses between BRAF V600E mutation group and BRAF V600E wild group

From: Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China

Index β SE Wals Sig. HR 95%CI
upper lower
Lymph node metastasis −2.363 0.526 20.154 < 0.001 0.094 0.034 0.264
131I radiotherapy 2.032 0.526 14.930 < 0.001 7.628 2.721 21.378
Pathology
(PTC/PTMC)
−0.418 0.334 1.564 0.211 0.659 0.342 1.267